Royal Bank of Canada’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $260M | Sell |
|
|||||
|
2025
Q2 | $241M | Buy |
|
|||||
|
2025
Q1 | $186M | Buy |
|
|||||
|
2024
Q4 | $159M | Sell |
|
|||||
|
2024
Q3 | $194M | Buy |
|
|||||
|
2024
Q2 | $190M | Buy |
|
|||||
|
2024
Q1 | $163M | Buy |
|
|||||
|
2023
Q4 | $158M | Buy |
|
|||||
|
2023
Q3 | $156M | Buy |
|
|||||
|
2023
Q2 | $160M | Sell |
|
|||||
|
2023
Q1 | $159M | Buy |
|
|||||
|
2022
Q4 | $144M | Sell |
|
|||||
|
2022
Q3 | $128M | Sell |
|
|||||
|
2022
Q2 | $157M | Sell |
|
|||||
|
2022
Q1 | $160M | Sell |
|
|||||
|
2021
Q4 | $144M | Sell |
|
|||||
|
2021
Q3 | $151M | Buy |
|
|||||
|
2021
Q2 | $118M | Sell |
|
|||||
|
2021
Q1 | $102M | Buy |
|
|||||
|
2020
Q4 | $98.9M | Buy |
|
|||||
|
2020
Q3 | $98.9M | Buy |
|
|||||
|
2020
Q2 | $95.4M | Buy |
|
|||||
|
2020
Q1 | $79.2M | Buy |
|
|||||
|
2019
Q4 | $82.8M | Buy |
|
|||||
|
2019
Q3 | $72M | Sell |
|
|||||
|
2019
Q2 | $67M | Sell |
|
|||||
|
2019
Q1 | $71.3M | Sell |
|
|||||
|
2018
Q4 | $81.1M | Sell |
|
|||||
|
2018
Q3 | $88.1M | Sell |
|
|||||
|
2018
Q2 | $85M | Sell |
|
|||||
|
2018
Q1 | $100M | Sell |
|
|||||
|
2017
Q4 | $102M | Buy |
|
|||||
|
2017
Q3 | $93.6M | Buy |
|
|||||
|
2017
Q2 | $63.3M | Buy |
|
|||||
|
2017
Q1 | $51.5M | Buy |
|
|||||
|
2016
Q4 | $32M | Buy |
|
|||||
|
2016
Q3 | $37.7M | Buy |
|
|||||
|
2016
Q2 | $21.4M | Sell |
|
|||||
|
2016
Q1 | $20.3M | Buy |
|
|||||
|
2015
Q4 | $19.9M | Sell |
|
|||||
|
2015
Q3 | $19.3M | Buy |
|
|||||
|
2015
Q2 | $11.9M | Buy |
|
|||||
|
2015
Q1 | $7.25M | Buy |
|
|||||
|
2014
Q4 | $7.18M | Buy |
|
|||||
|
2014
Q3 | $7.12M | Sell |
|
|||||
|
2014
Q2 | $8.72M | Sell |
|
|||||
|
2014
Q1 | $22.2M | Buy |
|
|||||
|
2013
Q4 | $18.1M | Sell |
|
|||||
|
2013
Q3 | $16M | Buy |
|
|||||
|
2013
Q2 | $12.7M | Buy |
|